In contrast, monoallelic GBA1 mutations are present in ~ 10% of the patients affected by PD, representing thus the main genetic risk for PD and linking GCase dysfunction to α-synuclein accumulation15. This evidence concerns the gene GBA1 and Parkinson disease.